logo
Select company
Select metric
-236.11%EBITDA Margin
VS
Market
9
Sector
31
Industry
55
History
-
$ 3.13Close
$ 1.26 - $ 4.19 52-Week Range
Ticker Information

Ticker

MGX

Company Name

METAGENOMI INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

METAGENOMI INC - EBITDA Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MGX - EBITDA % Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA MarginRevenues
6/30/2025$ -79.73M-236.11%$ 33.77M
3/31/2025$ -73.08M-161.46%$ 45.26M
12/31/2024$ -73.52M-140.59%$ 52.3M
9/30/2024$ -65.85M-119.56%$ 55.08M
12/31/2023$ -51.81M-115.77%$ 44.76M
12/31/2022$ -37.9M-220.35%$ 17.2M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • METAGENOMI INC's latest trailing twelve months (TTM) EBITDA % stands at -220.35%.
  • Over the past 5 years, METAGENOMI INC's average EBITDA % has been -165.64%.
  • The median EBITDA % for METAGENOMI INC during this period was -151.02%
  • METAGENOMI INC reached its highest EBITDA % over the past 5 years at -115.77%.
  • The lowest EBITDA % recorded by METAGENOMI INC in the same timeframe -236.11%

METAGENOMI INC's EBITDA % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA % Benchmarks
CompanyEBITDA %
ICCC : IMMUCELL CORP 15.8%WHWK : WHITEHAWK THERAPEUTICS INC -45.88%MRSN : MERSANA THERAPEUTICS INC -188.64%IRD : OPUS GENETICS INC -377.65%VRCA : VERRICA PHARMACEUTICALS INC -262.1%HYFT : MINDWALK HOLDINGS CORP -123.06%EQ : EQUILLIUM INC -119%BRNS : BARINTHUS BIOTHERAPEUTICS PLC -401.47%DOMH : DOMINARI HOLDINGS INC -35.03%IVVD : INVIVYD INC -231.15%

Definition of EBITDA Margin

[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
EBITDA / Revenues
(=) EBITDA %
EBITDA % for METAGENOMI INC is calculated as follows: EBITDA [ $ -37.9M ] / Revenues [ $ 17.2M ]
(=) EBITDA % [ -220.35% ]

MGX - EBITDA Margin, Last 5 years

-236.11%

Minimum

Jun 30, 2025

-115.77%

Maximum

Dec 31, 2023

-165.64%

Average

-151.02%

Median

EBITDA % Benchmark Analysis

The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.15% with a standard deviation of 26.84%.
The following table provides additional summary stats:
EBITDA % in the Market:
filtered constituents3.29K
min-74.98%
max97.73%
average16.15%
median14.67%
std26.84%